A man residing in Greater Manchester shared his experience of losing two inches in height due to an incurable blood cancer diagnosis. Matthew Padley, a 60-year-old electrical draughtsman from Hyde, began experiencing back spasms in September 2022. Initially, he disregarded the pain and managed it with over-the-counter painkillers until January of the following year when he was informed that the back damage might be linked to early-stage osteoporosis.
His myeloma diagnosis came in May 2023, a type of blood cancer affecting a significant number of individuals in the UK. By the time of diagnosis, the disease had already inflicted severe harm to his spine and bones.
Matthew expressed his shock at the diagnosis, stating, “It took a while to come to terms with it. Being told it’s incurable is tough. I’ve lost two inches in height due to the damage.” Regarding his diagnostic journey, he recounted booking an appointment with a physiotherapist at his GP’s office in January, leading to an X-ray that revealed the extent of the damage to his back.
Further tests confirmed the presence of myeloma, a type of blood cancer that accounts for a notable percentage of blood cancers and overall cancers. Myeloma UK highlighted the challenge in diagnosing myeloma promptly due to its vague symptoms often mistaken for age-related issues or minor ailments.
After undergoing chemotherapy and a stem cell transplant, Matthew faced various health challenges, including hives, vision problems, low blood pressure, and recurrent infections. Despite the physical and mental strain, he found relief in achieving remission and focusing on living life to the fullest.
Matthew emphasized the importance of not letting myeloma define one’s identity and credited his support system, including his wife, family, and healthcare professionals at The Christie Cancer Centre at Tameside Hospital. He commended the center for its exceptional care and acknowledged the impact of their support on patients dealing with myeloma.
In conclusion, Matthew expressed gratitude for the care received during his battle with myeloma and emphasized the significance of having a dedicated and compassionate healthcare team for patients coping with the challenges of an incurable cancer like myeloma.